Read + Share
Nierengarten MB. AACR 2024 presents advancements in pancreatic and gastric cancers: Promising
evidence has been found for the therapeutic potential of a neoantigen-based
cancer vaccine used in the adjuvant setting. Cancer 2024;130:2244.
PMID: 38849706
|
 |
|
